Gem Pharmatech Co.

BiotechnologySeries BNanjing, Chinagempharmatech.com

Latest round

Series B

Last raised

Sep 2020

Total raised

$82M

Investors

7

About Gem Pharmatech Co.

,Ltd is a biotechnology company that focuses on the research and development of humanization model and drug screening technology. In 2022, the company was listed on the Shanghai Stock Exchange. Its stock code is 688046., Ltd., Ltd. The company's main products include spotted mice, tool mice, germ-free mice and disease models. All protein-coding and non-coding genes that can be used in the design strategy of spotted mouse are CKO/KO modelling one by one. The company's products are used in basic research and new drug development fields such as gene function cognition, disease mechanism analysis, drug target discovery, drug efficacy screening and verification.

Who invested in Gem Pharmatech Co.

7 investors across 2 rounds

See all investors in Gem Pharmatech Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 11, 2020

    Amount

    $59M

    Investors

    Locked

  2. Series A

    Jun 3, 2019

    Amount

    $23M

    Investors

    Locked

Questions about Gem Pharmatech Co.

Who invested in Gem Pharmatech Co.?

Gem Pharmatech Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Gem Pharmatech Co. raised?

Gem Pharmatech Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Gem Pharmatech Co. last raise money?

Gem Pharmatech Co.'s most recent round on record is a Series B, in Sep 2020.

What does Gem Pharmatech Co. do?

,Ltd is a biotechnology company that focuses on the research and development of humanization model and drug screening technology.

Where is Gem Pharmatech Co. headquartered?

Gem Pharmatech Co. is headquartered in Nanjing, China.

Which VCs invest in companies like Gem Pharmatech Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Gem Pharmatech Co.'s stage. Their profiles are linked below.

Raising like Gem Pharmatech Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.